AVTR · Avantor, Inc.
$14.50
+0.08 (+0.55%)
At close · Aug 26
Market Cap
$9.88B
Shares
682.76M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$6.55B
-3.4%
FY2025
Net Income
-$530.2M
-174.5%
FY2025
Gross Margin
32.65%
-1pp
FY2025
Operating Margin
-3.76%
-19.8pp
FY2025
Diluted EPS
-$0.78
-175%
FY2025
Operating Cash Flow
$623.8M
-25.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $6.55B | $6.55B | $6.78B | $6.97BG | $7.51B | $7.39B | $6.39B | $6.04B | $5.86B | $1.25B | |
| — | $4.45B | $4.41B | $4.5B | $4.6B | $4.91B | $4.88B | $4.31B | $4.12B | $4.04B | $814.6M | |
| — | $2.11B | $2.14B | $2.28B | $2.36B | $2.6B | $2.5B | $2.08B | $1.92B | $1.82B | $432.8M | |
| — | — | 32.65% | 33.6% | 33.93% | 34.65% | 33.88% | 32.54% | 31.8% | 31.03% | 34.7% | |
| — | $1.61B | $1.6B | $1.64B | $1.51B | $1.47B | $1.53B | $1.37B | $1.37B | $1.41B | $449.7M | |
| — | — | $301.1M | $299.8M | $307.7M | $318.3M | $290.8M | $307.5M | $312.3M | $321.3M | $65.2M | |
| — | $415.5M | $410.2M | $405.5M | $402.3M | $405.5M | $379.2M | $395.4M | $398.9M | $404.6M | $99.2M | |
| — | — | $29.8M | $82.8M | $26.5M | $3.5M | $5.3M | $11.8M | $24.3M | $81.2M | $29.6M | |
| — | -$294.1M | -$246.2M | $1.08B | $696.4M | $1.13B | $972.2M | $706.8M | $551.8M | $413.5M | -$210.4M | |
| — | — | -3.76% | 15.99% | 10% | 15.04% | 13.16% | 11.05% | 9.14% | 7.05% | -16.87% | |
| — | $121.4M | $164M | $1.49B | $1.1B | $1.54B | $1.35B | $1.1B | $950.7M | $818.1M | -$111.2M | |
| — | $170.5M | $169.8M | $218.8M | $284.8M | $265.8M | $217.4M | $307.6M | $440M | $523.8M | $200.9M | |
| — | $44.8M | $42.2M | $75.1M | $65.2M | $15.9M | $1.9M | — | — | — | — | |
| — | -$1.7M | -$20.7M | -$1.2M | $5.8M | -$800K | $10.6M | $9.9M | $2.5M | -$3.5M | $7.5M | |
| — | -$471.5M | -$441.3M | $853.9M | $410.5M | $851.1M | $753M | $62.3M | $40.6M | -$113.8M | -$460.2M | |
| — | $79.9M | $88.9M | $142.4M | $89.4M | $164.6M | $180.4M | -$54.3M | $2.8M | -$26.9M | -$314.9M | |
| — | -$551.4M | -$530.2M | $711.5M | $321.1M | $686.5M | $572.6M | $116.6M | $37.8M | -$86.9M | -$112.7M | |
| — | — | -8.09% | 10.49% | 4.61% | 9.14% | 7.75% | 1.82% | 0.63% | -1.48% | -9.03% | |
| — | — | — | — | — | — | — | — | $0 | $0 | -$32.6M | |
| — | -$551.4M | -$530.2M | $711.5M | $321.1M | $662.3M | $508M | $52M | -$335.1M | -$356.4M | -$414.9M | |
| — | -$477.4M | -$363.1M | $596.5M | $352.4M | $629.4M | $507.7M | $224.2M | $18.4M | -$179.8M | -$45.4M | |
| USD/shares | — | — | -$0.78 | $1.05 | $0.48 | $1.02 | $0.86 | $0.09 | -$0.84 | -$2.69 | — |
| USD/shares | $0.80 – $0.83* | — | -$0.78 | $1.04G | $0.47G | $1.01G | $0.85 | $0.09 | -$0.84 | -$2.69 | — |
| shares | — | — | 680.6M | 679.6M | 675.6M | 650.9M | 590.5M | 576.3M | 401.2M | 132.7M | 151.1M |
| shares | — | — | 680.6M | 681.9M | 678.4M | 679.4M | 599.6M | 583.4M | 401.2M | 132.7M | 151.1M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $75.1M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
2.05×
Peer median 3.55×
EV/EBIT
—
Peer median 34.00×
P/E (TTM)
—
Peer median 36.68×
Peer medians compare against the 24 similar-size Medical Instruments & Supplies companies (of 46 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Laboratory Solutions Segment | $4,399,700,000 | $4,610,100,000 | $4,738,300,000 | $5,002,400,000 | — | — | — | — |
| Bioscience Production Segment | $2,152,500,000 | $2,173,500,000 | $2,228,900,000 | $2,510,000,000 | — | — | — | — |
| AMEA Segment | — | — | — | — | $471,400,000 | $375,400,000 | $353,500,000 | $308,100,000 |
| Americas Segment | — | — | — | — | $4,237,400,000 | $3,731,500,000 | $3,584,800,000 | $3,460,900,000 |
| Europe Segment | — | — | — | — | $2,677,300,000 | $2,286,700,000 | $2,102,000,000 | $2,095,300,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Proprietary Materials and Consumables | $3,448,900,000 | $3,615,100,000 | $3,720,200,000 | $4,024,700,000 | $2,548,200,000 | $2,043,600,000 | $1,765,400,000 | $1,688,300,000 |
| Third Party Materials and Consumables | $3,103,300,000 | $3,168,500,000 | $3,247,000,000 | $3,487,700,000 | $2,906,300,000 | $2,671,800,000 | $2,583,600,000 | $2,570,900,000 |
| Equipment and Instrumentation | — | — | — | — | $1,009,000,000 | $860,700,000 | $912,400,000 | $909,100,000 |
| Services and Specialty Procurement | — | — | — | — | $922,600,000 | $817,500,000 | $778,900,000 | $696,000,000 |
Key facts
CIK
1722482
CUSIP
05352A100
13F (30d)
376 filings
374 filers
Visit website
Investor relations